-DOCSTART- -X- O
Macrophage -X- _ O
colony-stimulating -X- _ O
factor -X- _ O
( -X- _ O
CSF1 -X- _ O
) -X- _ O
is -X- _ O
an -X- _ O
essential -X- _ O
growth -X- _ O
and -X- _ O
differentiation -X- _ O
factor -X- _ O
for -X- _ O
cells -X- _ O
of -X- _ O
the -X- _ O
macrophage -X- _ O
lineage. -X- _ O
To -X- _ O
explore -X- _ O
the -X- _ O
role -X- _ O
of -X- _ O
CSF1 -X- _ O
in -X- _ O
steady-state -X- _ O
control -X- _ O
of -X- _ O
monocyte -X- _ O
production -X- _ O
and -X- _ O
differentiation -X- _ O
and -X- _ O
tissue -X- _ O
repair -X- _ O
, -X- _ O
we -X- _ O
previously -X- _ O
developed -X- _ O
a -X- _ O
bioactive -X- _ O
protein -X- _ O
with -X- _ O
a -X- _ O
longer -X- _ O
half-life -X- _ O
in -X- _ O
circulation -X- _ O
by -X- _ O
fusing -X- _ O
pig -X- _ O
CSF1 -X- _ O
with -X- _ O
the -X- _ O
Fc -X- _ O
region -X- _ O
of -X- _ O
pig -X- _ O
IgG1a. -X- _ O
CSF1-Fc -X- _ B-Intervention
administration -X- _ O
to -X- _ O
pigs -X- _ B-Patient
expanded -X- _ O
progenitor -X- _ B-Outcome
pools -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
marrow -X- _ I-Outcome
and -X- _ I-Outcome
selectively -X- _ I-Outcome
increased -X- _ I-Outcome
monocyte -X- _ I-Outcome
numbers -X- _ I-Outcome
and -X- _ I-Outcome
their -X- _ I-Outcome
expression -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
maturation -X- _ I-Outcome
marker -X- _ I-Outcome
CD163. -X- _ I-Outcome
There -X- _ O
was -X- _ O
a -X- _ O
rapid -X- _ B-Outcome
increase -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
size -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
liver -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
extensive -X- _ I-Outcome
proliferation -X- _ I-Outcome
of -X- _ I-Outcome
hepatocytes -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
increased -X- _ I-Outcome
macrophage -X- _ I-Outcome
infiltration. -X- _ I-Outcome
Despite -X- _ O
the -X- _ O
large -X- _ O
influx -X- _ O
of -X- _ O
macrophages -X- _ O
, -X- _ O
there -X- _ O
was -X- _ O
no -X- _ B-Outcome
evidence -X- _ I-Outcome
of -X- _ I-Outcome
liver -X- _ I-Outcome
injury -X- _ I-Outcome
and -X- _ I-Outcome
no -X- _ I-Outcome
increase -X- _ I-Outcome
in -X- _ I-Outcome
circulating -X- _ I-Outcome
liver -X- _ I-Outcome
enzymes. -X- _ I-Outcome
Microarray -X- _ B-Outcome
expression -X- _ I-Outcome
profiling -X- _ I-Outcome
of -X- _ I-Outcome
livers -X- _ I-Outcome
identified -X- _ I-Outcome
increased -X- _ I-Outcome
expression -X- _ I-Outcome
of -X- _ I-Outcome
macrophage -X- _ I-Outcome
markers -X- _ I-Outcome
, -X- _ I-Outcome
i.e. -X- _ I-Outcome
, -X- _ I-Outcome
cytokines -X- _ I-Outcome
such -X- _ I-Outcome
as -X- _ I-Outcome
TNF -X- _ I-Outcome
, -X- _ I-Outcome
IL1 -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
IL6 -X- _ I-Outcome
known -X- _ I-Outcome
to -X- _ I-Outcome
influence -X- _ I-Outcome
hepatocyte -X- _ I-Outcome
proliferation -X- _ I-Outcome
, -X- _ I-Outcome
alongside -X- _ I-Outcome
cell -X- _ I-Outcome
cycle -X- _ I-Outcome
genes. -X- _ I-Outcome
The -X- _ O
analysis -X- _ O
also -X- _ O
revealed -X- _ O
selective -X- _ O
enrichment -X- _ O
of -X- _ O
genes -X- _ O
associated -X- _ O
with -X- _ O
portal -X- _ O
, -X- _ O
as -X- _ O
opposed -X- _ O
to -X- _ O
centrilobular -X- _ O
regions -X- _ O
, -X- _ O
as -X- _ O
seen -X- _ O
in -X- _ O
hepatic -X- _ O
regeneration. -X- _ O
Combined -X- _ B-Outcome
with -X- _ I-Outcome
earlier -X- _ I-Outcome
data -X- _ I-Outcome
from -X- _ I-Outcome
the -X- _ I-Outcome
mouse -X- _ I-Outcome
, -X- _ I-Outcome
this -X- _ I-Outcome
study -X- _ I-Outcome
supports -X- _ I-Outcome
the -X- _ I-Outcome
existence -X- _ I-Outcome
of -X- _ I-Outcome
a -X- _ I-Outcome
CSF1-dependent -X- _ I-Outcome
feedback -X- _ I-Outcome
loop -X- _ I-Outcome
, -X- _ I-Outcome
linking -X- _ I-Outcome
macrophages -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
liver -X- _ I-Outcome
with -X- _ I-Outcome
bone -X- _ I-Outcome
marrow -X- _ I-Outcome
and -X- _ I-Outcome
blood -X- _ I-Outcome
monocytes -X- _ I-Outcome
, -X- _ I-Outcome
to -X- _ I-Outcome
mediate -X- _ I-Outcome
homeostatic -X- _ I-Outcome
control -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
size -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
liver. -X- _ I-Outcome
The -X- _ I-Outcome
results -X- _ I-Outcome
also -X- _ I-Outcome
provide -X- _ I-Outcome
evidence -X- _ I-Outcome
of -X- _ I-Outcome
safety -X- _ I-Outcome
and -X- _ I-Outcome
efficacy -X- _ I-Outcome
for -X- _ I-Outcome
possible -X- _ I-Outcome
clinical -X- _ I-Outcome
applications -X- _ I-Outcome
of -X- _ I-Outcome
CSF1-Fc -X- _ I-Outcome
. -X- _ O

